Haldol

Haldol is the name used in the novel for haloperidol, a medication given to Thomas Birdsey during his confinement at Hatch. Its effects are presented as mixed rather than simply curative: after several days, it begins to lessen Thomas’s agitation, while the prospect of increasing the dose raises concerns about how medication may affect him. Through this treatment, the novel makes a practical clinical decision part of a broader struggle over Thomas’s well-being and the authority to define it.

Use in Thomas’s Treatment

After Thomas’s transfer to Hatch, Dominick Birdsey is initially unable to visit while his security clearance is pending. He relies on daily telephone updates from Lisa Sheffer and conversations with Thomas’s psychologist, Dr. Patel. During the first week and a half, Thomas is described as eating and sleeping satisfactorily and as having developed a rapport with Sheffer, whom he appears to trust. He remains generally uncommunicative with other patients in Unit Two and is troubled by the surveillance cameras throughout the unit.

Thomas has been taking Haldol again for several days by this point, and the medication is beginning to reduce his agitation. The account places that improvement alongside other indicators of his condition, including the successful treatment of an infection at his skin graft and stable vital signs. It does not present the drug as the sole explanation for his progress, or suggest that a reduction in agitation resolves the difficulties of his confinement. Instead, Haldol is one part of a developing treatment plan, observed alongside Thomas’s daily functioning and relationships with staff.

Effects and the Question of Dosage

A later disturbance prompts renewed discussion of Thomas’s medication. His restraints are removed by midmorning, and Dr. Patel explains that people experiencing paranoia may sometimes become more symptomatic and act out. Thomas remains withdrawn afterward, including with Sheffer, and declines to return to the dining hall at lunch, eating only fruit and cookies. Dr. Patel also tells Dominick that she has had a productive session with Thomas and that the staff psychiatrist, Dr. Chase, is considering increasing his Haldol dose.

Dr. Patel describes the trade-off involved in neuroleptic medication: it can lessen delusions and hallucinations, but may also intensify negative symptoms, including diminished affect and tremors. Her explanation gives the disagreement a clinical basis as well as an emotional one. A medication may reduce some of the symptoms that trouble Thomas while creating other burdens that are visible to him and to the people who know him.

Dominick’s Objection and Dr. Patel’s Advocacy

Dominick resists the possibility of a higher dose. Drawing on his experience of Thomas’s previous hospitalizations, he recalls that an earlier increase left Thomas markedly stiff and with pronounced involuntary movements. He fears that medication could suppress Thomas’s voices and agitation at the cost of leaving him dulled and physically unsettled. He also stresses that Thomas dislikes taking even the smaller dose and says it makes him feel unwell. In Dominick’s view, increasing it after a disruptive episode risks treating staff convenience as though it were Thomas’s best interest.

Dr. Patel does not dismiss this concern. She insists that she is Thomas’s advocate, not an opponent, and tells Dominick that she has advised Dr. Chase against increasing the haloperidol, judging the change probably ill-advised. The exchange distinguishes a proposed dose adjustment from an action already taken: the evidence establishes that an increase is under consideration and that Dr. Patel opposes it, but does not establish that Thomas’s dose is ultimately raised. Dominick’s challenge matters because it brings his long familiarity with his brother into a clinical conversation, while Dr. Patel’s response shows that advocacy can also come from within the treatment team.

Medication Within Institutional Care

The debate takes place under the constraints of Hatch, a maximum-security institute within the grounds of Three Rivers State Hospital. Thomas has entered under a Physician’s Emergency Certificate, which requires a fifteen-day observation period to assess whether he is dangerous to himself or others. The institution’s security checks, monitoring, and restrictions form the setting in which treatment decisions are made; Thomas is not choosing medication in an ordinary outpatient relationship, and Dominick cannot simply take him home while the initial hold remains in effect.

The narrative therefore keeps symptom management and institutional control in view at once. Dr. Patel describes Hatch’s care as generally humane, while acknowledging that the wards have problems; Dominick’s own encounter with a guard has made him distrustful of the institution’s assurances. Haldol becomes a particularly concrete point of disagreement within that larger tension. A reduction in agitation can matter to Thomas’s treatment, but it does not by itself answer whether the dose is appropriate, how its costs should be weighed, or whose judgment should govern.

Narrative Significance

Haldol is not treated as a simple symbol of either healing or coercion. Its reported benefit is specific: Thomas’s agitation begins to ease after he resumes taking it. The risk is also specific: both Thomas’s dislike of the medication and his brother’s memory of earlier adverse effects make a proposed increase consequential. The same treatment can be understood as symptom relief by clinicians and as a threat to Thomas’s alertness and individuality by Dominick, who fears that calm might be mistaken for recovery.

By leaving the proposed increase unresolved in the available account, the episode preserves the conflict rather than converting it into a verdict on medication. Thomas’s treatment depends on clinical judgment, close observation, and a family member’s willingness to challenge the plan; none of those elements alone settles what is best for him. Haldol thus concentrates the novel’s concern with care inside a restrictive institution, where improvement, side effects, safety, and personal agency must be weighed together.